{
  "Variants Include": [
    {
      "Gene": "DJ1",
      "variants": [
        {
          "HGVS": "NM_007262.3:c.192G>C",
          "cDNA Change": {
            "transcript": "NM_007262.3",
            "ref": "G",
            "alt": "C",
            "position": "192"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "D",
            "position": "64"
          },
          "Description in input context": "c.192G>C (p.E64D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Early-onset Parkinson disease (EOPD), autosomal recessive",
    "MONDO": "MONDO:0005330"
  },
  "Experiment Method": [
    {
      "Assay Method": "PET Imaging with [18F]FP-CIT",
      "Material used": {
        "Material Source": "Human patient and sibling",
        "Material Name": "Patient of Turkish ancestry and his sister",
        "Description": "DAT binding measured in a patient with the p.E64D mutation and his unaffected sister."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_007262.3:c.192G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss of function (reduced DAT binding)",
          "Result Description": "Patient exhibited reduced DAT binding (loss of dopaminergic neurons), while the unaffected sister showed normal DAT binding."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal DAT binding levels (standard PET thresholds for Parkinson's disease)",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "DAT binding < 20% of control (standard for severe dopaminergic loss)",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunocytochemistry",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 and COS7 cells",
        "Description": "Cells overexpressing wild-type or mutant DJ1 (p.E64D) were analyzed for protein localization."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_007262.3:c.192G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Structural/functional alteration (altered localization)",
          "Result Description": "Wild-type DJ1 showed cytoplasmic localization, while p.E64D exhibited perinuclear aggregation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Wild-type localization (cytoplasmic distribution)",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Perinuclear aggregation or mislocalization",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "X-ray Crystallography",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Wild-type and p.E64D DJ1",
        "Description": "Protein structure analysis of wild-type and mutant DJ1."
      },
      "Readout type": "Structural",
      "Readout description": [
        {
          "Variant": "NM_007262.3:c.192G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Structural disruption (loss of α-helix stability)",
          "Result Description": "Mutant DJ1 showed reduced α-helix content compared to wild-type, leading to conformational instability."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Wild-type α-helix content > 80%",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "α-helix content < 50%",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}